SHANGHAI YIZHONG PHARMACEUTICAL CO., LTD.

Altre lingue Shanghai Yizhong Pharmaceutical Co., Ltd.

Azioni

688091

CNE1000050F4

Prezzo di chiusura Shanghai S.E. Altri mercati azionari 00:00:00 17/05/2024			Variaz. 5gg	Var. 1 gen.
28,6 ^CNY	-1,27%		-6,13%	-41,91%

30/04	Le azioni della Cina continentale sono in calo in vista della lunga festività del Labor Day, Hong Kong sale	RE
29/04	Shanghai Yizhong Pharmaceutical Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Mainland China stocks edge lower ahead of long Labor Day holiday, Hong Kong rises	30/04
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	26/02
Yizhong Pharmaceutical Starts Construction of Paclitaxel Polymer Micelles Production Facility; Shares Down 3%	05/02
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	29/10/23
Yizhong Pharmaceutical's Plant Passes Good Manufacturing Practice Inspection of Shanghai's Drug Regulator	27/10/23
Shanghai Yizhong Pharmaceutical Co., Ltd.(XSSC:688091) added to S&P Global BMI Index	18/09/23
Certain A Shares of Shanghai Yizhong Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-SEP-2023.	09/09/23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	17/08/23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23
Chinese Oncology Body Includes Yizhong Pharma's Drug in Non-Small Cell Lung Cancer Treatment Guidelines	24/04/23
Yizhong Pharma Gets Nod to Trial Lung Cancer Drug in China	17/04/23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/02/23
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	19/10/22
Shanghai Yizhong Pharmaceutical Co., Ltd.(SHSE:688091) added to Shanghai Stock Exchange A Share Index	09/09/22
Shanghai Yizhong Pharmaceutical Co., Ltd.(SHSE:688091) added to Shanghai Stock Exchange Composite Index	09/09/22
Certain A Shares of Shanghai Yizhong Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 9-SEP-2022.	09/09/22
Shanghai Yizhong Pharmaceutical’s CFO Steps Down; Successor Named	18/08/22
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	17/08/22
Shanghai Yizhong Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	17/04/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Shanghai Yizhong Pharmaceutical Co., Ltd.

Azioni

688091

CNE1000050F4

Altre lingue

Filtri